ANI Pharmaceuticals

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$237,462
$247,060
$227,813
$211,371
Gross Profit
122,961
237,560
111,792
136,756
EBITDA
59,625
76,931
61,159
39,244
EBIT
38,706
54,318
38,527
15,963
Net Income
29,492
27,490
24,134
8,549
Net Change In Cash
237,462
247,060
227,813
211,371
Free Cash Flow
52,301
6,507
37,892
68,903
Cash
311,176
285,585
262,610
217,797
Basic Shares
21,544
21,228
21,093
20,308

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$883,366
$614,376
$486,816
$316,385
Gross Profit
450,639
364,166
305,303
177,600
EBITDA
207,268
63,121
106,603
25,040
EBIT
115,851
-4,610
46,812
-34,613
Net Income
78,337
-18,522
18,779
-47,896
Net Change In Cash
883,366
614,376
486,816
316,385
Cost of Revenue
-52,067
Free Cash Flow
171,390
47,064
100,448
-47,658
Cash
285,585
144,861
221,121
48,228
Basic Shares
21,228
19,318
18,194
16,260

Earnings Calls

QuarterEPS
2026-03-31
$2.05
2025-12-31
$2.33
2025-09-30
$2.04
2025-06-30
$0.36